Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1057 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-04-09 (bizjournals.com)
Charles River Laboratories sells South San Francisco facility to Portuguese biotech company FairJourney - San Francisco Business Times
Portuguese biotech FairJourney Biologics has acquired South San Francisco antibody R&D facility from Charles River Labs, expanding to North America.
Read more
2025-03-04 (biospace.com)
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility -
Acquisition of Charles River site, previously Distributed Bio, strengthens antibody discovery capabilities with SuperHuman libraries and Yeast Display platform
Read more
2025-02-17 (boersen-zeitung.de)
"Simcorp is a long-term industry Bet by Deutsche Börse" |
Former Simcorp CEO Christian Kromann moved up to the Deutsche Börse Executive Board in January, where he oversees Investment Management Solutions. In an interview, he talks about his vision for the strategically important business division.
Read more
2025-02-12 (defenseworld.net)
Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -
Read Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World
Read more
2025-01-27 (globenewswire.com)
Protein Binding Assays Research Report 2024: Global Market to Reach $1.47 Billion by 2035, Driven by Accelerated Drug Development, & Strategic Collaborations and Partnerships
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Protein Binding Assays Market by Product and Services, by Technology, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.
Read more
2025-01-27 (globenewswire.com)
Protein Binding Assays Research Report 2024: Global Market to Reach $1.47 Billion by 2035, Driven by Accelerated Drug Development, & Strategic Collaborations and Partnerships
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Protein Binding Assays Market by Product and Services, by Technology, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.
Read more
2025-01-24 (marketbeat.com)
Veracity Capital LLC Acquires New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Veracity Capital LLC purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,191 shares of the medical research company'
Read more
2024-10-18 (citybiz.co)
Breakthrough Properties Joined by San Diego Mayor Todd Gloria to Celebrate the Opening of Torrey View By Breakthrough Development
Fully Leased Life Science Campus is Now Home to Leading Companies Including Pfizer and BD Biosciences Breakthrough Properties was joined by... Read More
Read more
2024-09-29 (defenseworld.net)
Canada Pension Plan Investment Board Acquires New Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Read Canada Pension Plan Investment Board Acquires New Stake in Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World
Read more